CASI Pharmaceuticals CASIF
OTC CASIF
$0.12 +0.01 (+9.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Total Non-Current Liabilities (2021 - 2026)

Updated

CASI Pharmaceuticals (CASIF) recorded Total Non-Current Liabilities of $11.15 million in Q2 2026, down 70.4% from $37.74 million a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, CASI Pharmaceuticals reported Total Non-Current Liabilities of $4.62 million, down 71.1% from FY2024.

  • Annual Total Non-Current Liabilities has a four-year compound annual growth rate of -29.6% (FY2021 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $15.96 million in FY2024 (-20.9%), $20.18 million in FY2023 (+24.3%), $16.23 million in FY2022 (-13.4%) and $18.75 million in FY2021.
  • Quarterly Total Non-Current Liabilities has ranged from $4.62 million in Q4 2025 to $39.42 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Total Non-Current Liabilities rose in two of the last five quarters, with an average decline of 20.7%.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 34.5% in Q2 2025, against a decline of 71.1% in Q4 2025 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 CASI Pharmaceuticals 2.47 Mn -18.36 Mn - 11.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.15 Mn
Dec 31, 2025 4.62 Mn
Sep 30, 2025 39.42 Mn
Jun 30, 2025 37.74 Mn
Mar 31, 2025 33.71 Mn
Dec 31, 2024 15.96 Mn
Jun 30, 2024 28.05 Mn
Mar 31, 2024 27.13 Mn
Dec 31, 2023 20.18 Mn
Sep 30, 2023 33.47 Mn
Jun 30, 2023 33.52 Mn
Mar 31, 2023 36.68 Mn
Dec 31, 2022 16.23 Mn
Dec 31, 2021 18.75 Mn
API Access

CASI Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CASIF&period=max&api_key=YOUR_API_KEY